Literature DB >> 27206432

Molecular Mechanisms of Vascular Dementia: What Can Be Learned from Animal Models of Chronic Cerebral Hypoperfusion?

Si-Qi Du1, Xue-Rui Wang1, Ling-Yong Xiao2, Jian-Feng Tu2, Wen Zhu1, Tian He1, Cun-Zhi Liu3.   

Abstract

Vascular dementia (VD) is defined as a progressive neurodegenerative disease of cognitive decline, attributable to cerebrovascular factors. Numerous studies have demonstrated that chronic cerebral hypoperfusion (CCH) is associated with the initiation and progression of VD and Alzheimer's disease (AD). Suitable animal models were established to replicate such pathological condition in experimental research, which contributes largely to comprehending causal relationships between CCH and cognitive impairment. The most widely used experimental model of VD and CCH is permanent bilateral common carotid artery occlusion in rats. In CCH models, changes of learning and memory, cerebral blood flow (CBF), energy metabolism, and neuropathology initiated by ischemia were revealed. However, in order to achieve potential therapeutic targets, particular mechanisms in cognitive and neuropathological changes from CCH to dementia should be investigated. Recent studies have shown that hypoperfusion resulted in a chain of disruption of homeostatic interactions, including oxidative stress, neuroinflammation, neurotransmitter system dysfunction, mitochondrial dysfunction, disturbance of lipid metabolism, and alterations of growth factors. Evidence from experimental studies that elucidate the damaging effects of such imbalances suggests their critical roles in the pathogenesis of VD. The present review provides a summary of the achievements in mechanisms made with the CCH models, permits an understanding of the causative role played by CCH in VD, and highlights preventative and therapeutic prospects.

Entities:  

Keywords:  Chronic cerebral hypoperfusion; Cognition; Neuroinflammation; Oxidative stress; Vascular dementia

Mesh:

Year:  2016        PMID: 27206432     DOI: 10.1007/s12035-016-9915-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  140 in total

1.  Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis.

Authors:  Yu-dan Chen; Juan Zhang; Yue Wang; Jun-liang Yuan; Wen-li Hu
Journal:  Eur Neurol       Date:  2016-02-27       Impact factor: 1.710

2.  Involvement of dopamine D1 receptors of the hippocampal dentate gyrus in spatial learning and memory deficits in a rat model of vascular dementia.

Authors:  P Wan; S Wang; Y Zhang; J Lv; Q H Jin
Journal:  Pharmazie       Date:  2014-09       Impact factor: 1.267

3.  Changes in cerebral blood flow and postsynaptic muscarinic cholinergic activity in rats with bilateral carotid artery ligation.

Authors:  Y Ouchi; H Tsukada; T Kakiuchi; S Nishiyama; M Futatsubashi
Journal:  J Nucl Med       Date:  1998-01       Impact factor: 10.057

4.  Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents.

Authors:  Kayoko Nakaji; Masafumi Ihara; Chiaki Takahashi; Shigeyoshi Itohara; Makoto Noda; Ryosuke Takahashi; Hidekazu Tomimoto
Journal:  Stroke       Date:  2006-09-28       Impact factor: 7.914

Review 5.  Lipid signaling in neural plasticity, brain repair, and neuroprotection.

Authors:  Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

6.  Protective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion.

Authors:  Je-Seong Won; Jinsu Kim; Balasubramaniam Annamalai; Anandakumar Shunmugavel; Inderjit Singh; Avtar K Singh
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  Chronic brain ischemia induces the expression of glial glutamate transporter EAAT2 in subcortical white matter.

Authors:  Y Yatomi; R Tanaka; H Shimura; N Miyamoto; K Yamashiro; M Takanashi; T Urabe; N Hattori
Journal:  Neuroscience       Date:  2013-04-18       Impact factor: 3.590

Review 8.  Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment.

Authors:  Gary A Rosenberg; Maria Bjerke; Anders Wallin
Journal:  Stroke       Date:  2014-04-01       Impact factor: 7.914

9.  Cerebroprotective effect of Eclipta alba against global model of cerebral ischemia induced oxidative stress in rats.

Authors:  K P Mansoorali; T Prakash; D Kotresha; K Prabhu; N Rama Rao
Journal:  Phytomedicine       Date:  2012-08-27       Impact factor: 5.340

10.  Role of phosphatidylinositol(4,5)bisphosphate organization in membrane transport by the Unc104 kinesin motor.

Authors:  Dieter R Klopfenstein; Michio Tomishige; Nico Stuurman; Ronald D Vale
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

View more
  46 in total

1.  L-3-n-Butylphthalide Activates Akt/mTOR Signaling, Inhibits Neuronal Apoptosis and Autophagy and Improves Cognitive Impairment in Mice with Repeated Cerebral Ischemia-Reperfusion Injury.

Authors:  Jing Xu; Yaping Huai; Nan Meng; Yanhong Dong; Zhijuan Liu; Qianqian Qi; Ming Hu; Mingyue Fan; Wei Jin; Peiyuan Lv
Journal:  Neurochem Res       Date:  2017-06-15       Impact factor: 3.996

Review 2.  Protein Phosphatase 2A: a Double-Faced Phosphatase of Cellular System and Its Role in Neurodegenerative Disorders.

Authors:  Md Nematullah; M N Hoda; Farah Khan
Journal:  Mol Neurobiol       Date:  2017-02-21       Impact factor: 5.590

3.  Targeting TDP-43 Pathology Alleviates Cognitive and Motor Deficits Caused by Chronic Cerebral Hypoperfusion.

Authors:  Sai Sampath Thammisetty; Laurence Renaud; Vincent Picher-Martel; Yuan Cheng Weng; Frédéric Calon; Stephan Saikali; Jean-Pierre Julien; Jasna Kriz
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

Review 4.  Molecular mechanisms of cognitive impairment associated with stroke.

Authors:  Mandeep Kaur; Saurabh Sharma
Journal:  Metab Brain Dis       Date:  2022-01-14       Impact factor: 3.584

5.  Acupuncture inhibits TXNIP-associated oxidative stress and inflammation to attenuate cognitive impairment in vascular dementia rats.

Authors:  Si-Qi Du; Xue-Rui Wang; Wen Zhu; Yang Ye; Jing-Wen Yang; Si-Ming Ma; Cai-Shuo Ji; Cun-Zhi Liu
Journal:  CNS Neurosci Ther       Date:  2017-11-06       Impact factor: 5.243

6.  Neurological Changes in Vulnerable Brain Areas of Chronic Cerebral Hypoperfusion Mice.

Authors:  Siriluk Somredngan; Wachiryah Thong-Asa
Journal:  Ann Neurosci       Date:  2017-10-18

7.  Protective Impact of Edaravone Against ZnO NPs-induced Oxidative Stress in the Human Neuroblastoma SH-SY5Y Cell Line.

Authors:  Sanjiv Singh; Upendr Gautam; F V Manvi
Journal:  Cell Mol Neurobiol       Date:  2020-11-21       Impact factor: 5.046

Review 8.  Estrogen receptor involvement in vascular cognitive impairment and vascular dementia pathogenesis and treatment.

Authors:  Dianna H Nguyen; J Thomas Cunningham; Nathalie Sumien
Journal:  Geroscience       Date:  2020-09-09       Impact factor: 7.713

9.  Effect of Methylene Blue and PI3K-Akt Pathway Inhibitors on the Neurovascular System after Chronic Cerebral Hypoperfusion in Rats.

Authors:  Yunxia Li; Xin Wang; Meng Liu; Wei Zhang; Renren Li; Zhiyu Nie
Journal:  J Mol Neurosci       Date:  2020-06-08       Impact factor: 3.444

Review 10.  The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders.

Authors:  Michał Kosowski; Joanna Smolarczyk-Kosowska; Marcin Hachuła; Mateusz Maligłówka; Marcin Basiak; Grzegorz Machnik; Robert Pudlo; Bogusław Okopień
Journal:  Molecules       Date:  2021-05-11       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.